Live Breaking News & Updates on Ben Larman Johns Hopkins

Published: Apr 05, 2021
 
 
CAMBRIDGE, Mass. (BUSINESS WIRE) ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, today announced that Annalisa D’Andrea, Ph.D., has been appointed President and Chief Scientific Officer. Dr. D’Andrea brings more than 25 years of experience in translational research in immunology to ImmuneID.
“The addition of Annalisa as President and CSO is an important milestone for ImmuneID, as the company applies its platform to identify promising immunological therapeutic targets,” said Stephen Elledge, Ph.D., ImmuneID co-founder and Chair of ImmuneID SAB, Lasker Award winner, and The Gregor Mendel Professor of Genetics and Medicine, Harvard Medical School. “Annalisa’s experience advancing drug candidates to the clinic will be extremely valuable and I look forward to working with her.” ....

United Kingdom , Pitango Healthtech , Stephen Elledge Harvard , Annalisa Dandrea , Tomasz Kula Harvard , Stephen Elledge , Ben Larman Johns Hopkins , Bachelor Of Sciences , Kiniksa Pharmaceuticals , Longwood Fund Christoph Westphal , Harvard Medical School , Immuneid Inc , University Of Siena , University Of Pennsylvania , University Of Florence , Longwood Fund , Wistar Institute , Annalisad Andrea , Chief Scientific , Lasker Award , Gregor Mendel Professor , Harvard Medical , Christoph Westphal , Arch Venture Partners , Alta Partners , Chief Scientific Officer ,